Literature DB >> 12216325

Correction of dysfunctional fatty acid metabolism using peroxisome proliferator activated receptor gamma agonists.

Nicholas D Oakes1, Bengt Ljung, Germán Camejo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12216325      PMCID： PMC1308943     

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  33 in total

1.  Non-alcoholic steatohepatitis: another disease of affluence.

Authors:  O James; C Day
Journal:  Lancet       Date:  1999-05-15       Impact factor: 79.321

Review 2.  Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years.

Authors:  P J Randle
Journal:  Diabetes Metab Rev       Date:  1998-12

Review 3.  Peroxisome proliferator-activated receptor-gamma: from adipogenesis to carcinogenesis.

Authors:  L Fajas; M B Debril; J Auwerx
Journal:  J Mol Endocrinol       Date:  2001-08       Impact factor: 5.098

Review 4.  Metabolic cardiomyopathies.

Authors:  B Guertl; C Noehammer; G Hoefler
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

5.  Skeletal muscle triglyceride levels are inversely related to insulin action.

Authors:  D A Pan; S Lillioja; A D Kriketos; M R Milner; L A Baur; C Bogardus; A B Jenkins; L H Storlien
Journal:  Diabetes       Date:  1997-06       Impact factor: 9.461

6.  Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle.

Authors:  B A Ellis; A Poynten; A J Lowy; S M Furler; D J Chisholm; E W Kraegen; G J Cooney
Journal:  Am J Physiol Endocrinol Metab       Date:  2000-09       Impact factor: 4.310

Review 7.  Hypertriglyceridemic hyperapob: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus.

Authors:  A D Sniderman; T Scantlebury; K Cianflone
Journal:  Ann Intern Med       Date:  2001-09-18       Impact factor: 25.391

Review 8.  Lipotoxic diseases of nonadipose tissues in obesity.

Authors:  R H Unger; L Orci
Journal:  Int J Obes Relat Metab Disord       Date:  2000-11

9.  Contribution of muscle and liver to glucose-fatty acid cycle in humans.

Authors:  C Saloranta; V Koivisto; E Widén; K Falholt; R A DeFronzo; M Härkönen; L Groop
Journal:  Am J Physiol       Date:  1993-04

10.  Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner.

Authors:  K Motojima; P Passilly; J M Peters; F J Gonzalez; N Latruffe
Journal:  J Biol Chem       Date:  1998-07-03       Impact factor: 5.157
View more
  2 in total

1.  Dynamic changes in fat oxidation in human primary myocytes mirror metabolic characteristics of the donor.

Authors:  Barbara Ukropcova; Michele McNeil; Olga Sereda; Lilian de Jonge; Hui Xie; George A Bray; Steven R Smith
Journal:  J Clin Invest       Date:  2005-07       Impact factor: 14.808

2.  The PPAR α / γ Agonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid Utilization In Vivo in the Obese Zucker Rat.

Authors:  Kristina Wallenius; Ann Kjellstedt; Pia Thalén; Lars Löfgren; Nicholas D Oakes
Journal:  PPAR Res       Date:  2013-10-27       Impact factor: 4.964
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.